500_knpharmachain

Kuehne + Nagel has unveiled its new corporate plan to succeed the Focus + Excellence initiative that has run since 2014.

At the company’s capital markets presentation today in London, chief executive Detlef Trefzger said KN+ NextGen was effectively an umbrella term for a range of “transformative projects” ...

To read this article you need to subscribe.

Help us to continue to invest in award-winning independent journalism. For an introductory offer of just £70 a year, or £10 per month, get access to all our daily news stories and opinion. If you are already a registered user, please login below with your current account's email and password to subscribe. If you are not registered and want to subscribe, please register below to subscribe.
Current subscriber
New subscriber

Comment on this article


You must be logged in to post a comment.